Top Clinical Trials companies in Sweden by Total Liabilities

This ranking features the top 65 Clinical Trials companies in Sweden ranked by Total Liabilities, totaling a Total Liabilities of USD 7.17 B, for June 30, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2

Frequently Asked Questions

Which Clinical Trials company in Sweden has the highest Total Liabilities ?

The Clinical Trials company in Sweden with the highest Total Liabilities is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 3.16 B.
Which Clinical Trials company in Sweden has the lowest Total Liabilities ?

The Clinical Trials company in Sweden with the lowest Total Liabilities is CellaVision AB (publ) (Stockholm Stock Exchange: CEVI.ST) at None.

What are the top 10 Clinical Trials companies in Sweden by Total Liabilities ?

The top 10 Clinical Trials companies in Sweden by Total Liabilities are Swedish Orphan Biovitrum AB (publ), Elekta AB (publ), Arjo AB (publ), Vimian Group AB (publ), Vitrolife AB (publ), Hansa Biopharma AB (publ), RaySearch Laboratories AB (publ), Orexo AB (publ), Surgical Science Sweden AB (publ) and Magle Chemoswed Holding AB (publ).
What are the bottom 10 Clinical Trials companies in Sweden by Total Liabilities ?

The bottom 10 Clinical Trials companies in Sweden by Total Liabilities are CellaVision AB (publ), BrainCool AB (publ), Cantargia AB (publ), BioInvent International AB (publ), Alzinova AB (publ), BioArctic AB (publ), Aptahem AB (publ), AlzeCure Pharma AB (publ), Ascelia Pharma AB (publ) and Corline Biomedical AB.